Impact of increased visceral and cardiac fat on cardiometabolic risk and disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Diabet. Med. 29, 622–627 (2012) Objective Previous studies have highlighted the associations between abdominal, cardiac or total fat accumulation and cardiovascular disease. The aim of this study was to investigate the impact of different ectopic fat depots on measurements of metabolic dysfunction and cardiovascular disease risk. Methods Using magnetic resonance imaging in 113 subjects, we measured abdominal (visceral and subcutaneous) and cardiac (epicardial and extra‐pericardial) fat depots and examined their association with overall (BMI) and abdominal obesity (waist circumference), dyslipidaemia (triglycerides, total and HDL cholesterol), glucose tolerance (by an oral glucose tolerance test) and insulin sensitivity, blood pressure and 10‐year coronary heart disease risk by Framingham score. Results Fat accumulation was proportional to the degree of obesity, with body fat ranging from 14 to 33 kg, visceral fat from 0.8 to 1.8 kg and cardiac fat from 134 to 236 g. Most cardiac fat (70% on average) was extra‐pericardial, with a wide variability for both cardiac depots (epicardial: 172–2008 mm 2; extra‐pericardial: 100–5056 mm 2). Only visceral and extra‐pericardial fat, but not epicardial or subcutaneous fat, could discriminate between subjects with three or more factors of the metabolic syndrome or medium‐to‐high coronary heart disease risk score. Controlling for gender and BMI by multivariable analysis, the best marker of reduced insulin sensitivity was visceral fat (partial r = −0.35); extra‐pericardial fat was the closest associate of increased blood pressure (partial r = 0.26) and both extra‐pericardial and visceral fat clustered with hypertriglyceridaemia (partial r = 0.29 and 0.24; both P < 0.02). Conclusion Increased epicardial fat per se does not necessarily translate into presence or prediction of disease. In contrast, increased deposition of visceral abdominal and extra‐pericardial mediastinal fat are both associated with an enhanced cardiovascular disease risk profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589
Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart
Iacobellis, G., Corradi, D., & Sharma, A. M. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0319 · Cited by 1,015
Iacobellis, G., Ribaudo, M. C., Assael, F., Vecci, E., Tiberti, C., Zappaterreno, A., Di Mario, U., & Leonetti, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030698 · Cited by 842 · cited 2×
“Cardiac fat is now recognized as a new cardiometabolic risk marker, as it is associated with increased insulin resistance, cardiovascular risk factors, visceral fat and, in general, with the metabolic syndrome [5,6].”
BackgroundGrundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
Lipid accumulation in non-adipose tissue and lipotoxicity
van Herpen, N. A., & Schrauwen-Hinderling, V. B. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.049 · Cited by 500 · cited 1×
“Fat accumulates mainly in subcutaneous depots, but sizeable amounts of adipose tissue are also deposited in the abdomen (between and within organs), in the thorax (as epicardial, mediastinal and/or intramyocardial fat), in the pancreas and in skeletal muscle [1].”
BackgroundEctopic lipids and organ function.
Szendroedi, J., & Roden, M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328321b3a8 · Cited by 200
Abdominal fat: does it predict the development of type 2 diabetes?
Gastaldelli, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1118 · Cited by 32 · cited 1×
“Visceral fat has been related to both metabolic and cardiovascular dysfunction [3,4].”
BackgroundSelf-citation
Cited by
Thomas, D. M., Bredlau, C., Bosy-Westphal, A., Mueller, M., Shen, W., Gallagher, D., Maeda, Y., McDougall, A., Peterson, C. M., Ravussin, E., et al. (2013) · Obesity · doi:10.1002/oby.20408 · Cited by 1,074
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Self-citationNeeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
“MetS disease risk tracks closely with VAT and ectopic (for example, cardiac) lipid and adipose tissue accumulation 48 as well as with hepatic steatosis and with MASLD.”
Self-citationEpicardial fat in heart failure patients with mid-range and preserved ejection fraction
van Woerden, G., Gorter, T. M., Westenbrink, B. D., Willems, T. P., van Veldhuisen, D. J., & Rienstra, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1283 · Cited by 265
Rabkin, S. W. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0107 · Cited by 197
Metadata
- Authors
- Sironi, A. M., Petz, R., De Marchi, D., Buzzigoli, E., Ciociaro, D., Positano, V., Lombardi, M., Ferrannini, E., & Gastaldelli, A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2012-04-16
- Volume
- 29
- Issue
- 5
- Pages
- 622-627
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1499497522
- Cited by
- 112
- References
- 7
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. https://app.cochat.ai/papers/10.1111/j.1464-5491.2011.03503.x
- The paper
- Sironi, A. M., Petz, R., De Marchi, D., Buzzigoli, E., Ciociaro, D., Positano, V., Lombardi, M., Ferrannini, E., & Gastaldelli, A. (2012). Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2011.03503.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.